nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisdexamfetamine—ADRA1B—Amitriptyline—migraine	0.274	0.523	CbGbCtD
Lisdexamfetamine—SLC6A2—Amitriptyline—migraine	0.25	0.477	CbGbCtD
Lisdexamfetamine—SLC6A2—locus ceruleus—migraine	0.0155	0.197	CbGeAlD
Lisdexamfetamine—SLC6A2—sympathetic nervous system—migraine	0.0122	0.156	CbGeAlD
Lisdexamfetamine—SLC6A2—autonomic nervous system—migraine	0.00822	0.105	CbGeAlD
Lisdexamfetamine—Phenacemide—SCN1A—migraine	0.00603	0.639	CrCbGaD
Lisdexamfetamine—SLC6A3—nerve—migraine	0.00573	0.073	CbGeAlD
Lisdexamfetamine—SLC18A2—Synaptic Vesicle Pathway—ATP1A2—migraine	0.00496	0.0721	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—nerve—migraine	0.00462	0.0589	CbGeAlD
Lisdexamfetamine—SLC18A2—Synaptic Vesicle Pathway—CACNA1A—migraine	0.00359	0.0521	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—brainstem—migraine	0.00325	0.0414	CbGeAlD
Lisdexamfetamine—ADRA1B—Monoamine GPCRs—HTR1D—migraine	0.00253	0.0368	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—brainstem—migraine	0.00246	0.0313	CbGeAlD
Lisdexamfetamine—ADRA1B—Monoamine GPCRs—HTR2B—migraine	0.00235	0.0342	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Amine ligand-binding receptors—HTR1D—migraine	0.00213	0.0309	CbGpPWpGaD
Lisdexamfetamine—Lisinopril—ACE—migraine	0.00201	0.213	CrCbGaD
Lisdexamfetamine—SLC6A2—brainstem—migraine	0.00198	0.0253	CbGeAlD
Lisdexamfetamine—ADRA1B—Amine ligand-binding receptors—HTR2B—migraine	0.00198	0.0287	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Synaptic Vesicle Pathway—SLC6A4—migraine	0.00194	0.0282	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Monoamine Transport—SLC6A4—migraine	0.00189	0.0275	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Neuronal System—KCNK18—migraine	0.00189	0.0274	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—head—migraine	0.00181	0.0231	CbGeAlD
Lisdexamfetamine—SLC18A2—head—migraine	0.0018	0.0229	CbGeAlD
Lisdexamfetamine—ADRA1B—nervous system—migraine	0.00172	0.0219	CbGeAlD
Lisdexamfetamine—SLC18A2—nervous system—migraine	0.0017	0.0217	CbGeAlD
Lisdexamfetamine—SLC6A3—Monoamine Transport—SLC6A4—migraine	0.00168	0.0244	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—central nervous system—migraine	0.00166	0.0211	CbGeAlD
Lisdexamfetamine—SLC18A2—central nervous system—migraine	0.00164	0.0209	CbGeAlD
Lisdexamfetamine—SLC18A2—cerebellum—migraine	0.0016	0.0204	CbGeAlD
Lisdexamfetamine—ADRA1B—Monoamine GPCRs—HTR1B—migraine	0.00153	0.0223	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Monoamine GPCRs—HTR1A—migraine	0.00148	0.0214	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Monoamine GPCRs—HTR2C—migraine	0.00143	0.0207	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—head—migraine	0.00136	0.0173	CbGeAlD
Lisdexamfetamine—ADRA1B—brain—migraine	0.00132	0.0167	CbGeAlD
Lisdexamfetamine—SLC18A2—brain—migraine	0.0013	0.0166	CbGeAlD
Lisdexamfetamine—ADRA1B—Amine ligand-binding receptors—HTR1B—migraine	0.00129	0.0187	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—nervous system—migraine	0.00129	0.0164	CbGeAlD
Lisdexamfetamine—ADRA1B—Monoamine GPCRs—HTR7—migraine	0.00125	0.0181	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—central nervous system—migraine	0.00124	0.0158	CbGeAlD
Lisdexamfetamine—ADRA1B—Amine ligand-binding receptors—HTR1A—migraine	0.00124	0.018	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—cerebellum—migraine	0.00121	0.0154	CbGeAlD
Lisdexamfetamine—SLC18A2—Transmission across Chemical Synapses—CACNA1A—migraine	0.0012	0.0175	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Amine ligand-binding receptors—HTR2C—migraine	0.0012	0.0174	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—KCNK18—migraine	0.00113	0.0163	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—head—migraine	0.0011	0.014	CbGeAlD
Lisdexamfetamine—ADRA1B—Amine ligand-binding receptors—HTR7—migraine	0.00105	0.0152	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—nervous system—migraine	0.00104	0.0132	CbGeAlD
Lisdexamfetamine—SLC6A2—central nervous system—migraine	0.001	0.0127	CbGeAlD
Lisdexamfetamine—SLC6A3—brain—migraine	0.000985	0.0125	CbGeAlD
Lisdexamfetamine—Palpitations—Verapamil—migraine	0.000977	0.00306	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Propranolol—migraine	0.000962	0.00301	CcSEcCtD
Lisdexamfetamine—Visual disturbance—Topiramate—migraine	0.000958	0.003	CcSEcCtD
Lisdexamfetamine—Convulsion—Verapamil—migraine	0.000958	0.003	CcSEcCtD
Lisdexamfetamine—Urticaria—Amitriptyline—migraine	0.000957	0.003	CcSEcCtD
Lisdexamfetamine—Hypertension—Verapamil—migraine	0.000955	0.00299	CcSEcCtD
Lisdexamfetamine—Skin disorder—Propranolol—migraine	0.000953	0.00298	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Amitriptyline—migraine	0.000953	0.00298	CcSEcCtD
Lisdexamfetamine—Hepatobiliary disease—Valproic Acid—migraine	0.000949	0.00297	CcSEcCtD
Lisdexamfetamine—Erectile dysfunction—Timolol—migraine	0.000923	0.00289	CcSEcCtD
Lisdexamfetamine—SLC18A2—Neuronal System—CACNA1A—migraine	0.000922	0.0134	CbGpPWpGaD
Lisdexamfetamine—Dry mouth—Verapamil—migraine	0.000921	0.00288	CcSEcCtD
Lisdexamfetamine—Diplopia—Topiramate—migraine	0.000908	0.00284	CcSEcCtD
Lisdexamfetamine—Weight decreased—Timolol—migraine	0.000906	0.00284	CcSEcCtD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—TRPM8—migraine	0.000904	0.0131	CbGpPWpGaD
Lisdexamfetamine—Anaphylactic shock—Verapamil—migraine	0.000903	0.00283	CcSEcCtD
Lisdexamfetamine—Disturbance in sexual arousal—Topiramate—migraine	0.000901	0.00282	CcSEcCtD
Lisdexamfetamine—Hallucination—Valproic Acid—migraine	0.000896	0.00281	CcSEcCtD
Lisdexamfetamine—Affect lability—Topiramate—migraine	0.000894	0.0028	CcSEcCtD
Lisdexamfetamine—Depression—Timolol—migraine	0.000891	0.00279	CcSEcCtD
Lisdexamfetamine—Insomnia—Propranolol—migraine	0.000888	0.00278	CcSEcCtD
Lisdexamfetamine—Psychotic disorder—Topiramate—migraine	0.000887	0.00278	CcSEcCtD
Lisdexamfetamine—Tachycardia—Verapamil—migraine	0.000881	0.00276	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Propranolol—migraine	0.000875	0.00274	CcSEcCtD
Lisdexamfetamine—ADRA1B—Monoamine GPCRs—HTR2A—migraine	0.000875	0.0127	CbGpPWpGaD
Lisdexamfetamine—Hyperhidrosis—Verapamil—migraine	0.000873	0.00273	CcSEcCtD
Lisdexamfetamine—Somnolence—Propranolol—migraine	0.000872	0.00273	CcSEcCtD
Lisdexamfetamine—Visual impairment—Valproic Acid—migraine	0.000868	0.00272	CcSEcCtD
Lisdexamfetamine—Irritability—Topiramate—migraine	0.000867	0.00271	CcSEcCtD
Lisdexamfetamine—Asthenia—Amitriptyline—migraine	0.000865	0.00271	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Propranolol—migraine	0.000864	0.0027	CcSEcCtD
Lisdexamfetamine—Erectile dysfunction—Gabapentin—migraine	0.000859	0.00269	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Propranolol—migraine	0.000853	0.00267	CcSEcCtD
Lisdexamfetamine—Erythema multiforme—Valproic Acid—migraine	0.000852	0.00267	CcSEcCtD
Lisdexamfetamine—Weight increased—Gabapentin—migraine	0.000849	0.00266	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Propranolol—migraine	0.000847	0.00265	CcSEcCtD
Lisdexamfetamine—Fatigue—Propranolol—migraine	0.000846	0.00265	CcSEcCtD
Lisdexamfetamine—Weight decreased—Gabapentin—migraine	0.000844	0.00264	CcSEcCtD
Lisdexamfetamine—Eye disorder—Valproic Acid—migraine	0.000842	0.00264	CcSEcCtD
Lisdexamfetamine—Constipation—Propranolol—migraine	0.000839	0.00263	CcSEcCtD
Lisdexamfetamine—Depression—Gabapentin—migraine	0.00083	0.0026	CcSEcCtD
Lisdexamfetamine—Abdominal pain upper—Topiramate—migraine	0.00083	0.0026	CcSEcCtD
Lisdexamfetamine—Stevens-Johnson syndrome—Gabapentin—migraine	0.000825	0.00258	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Amitriptyline—migraine	0.000825	0.00258	CcSEcCtD
Lisdexamfetamine—Acute coronary syndrome—Gabapentin—migraine	0.00082	0.00257	CcSEcCtD
Lisdexamfetamine—Toxic epidermal necrolysis—Topiramate—migraine	0.000818	0.00256	CcSEcCtD
Lisdexamfetamine—Insomnia—Verapamil—migraine	0.000816	0.00256	CcSEcCtD
Lisdexamfetamine—Myocardial infarction—Gabapentin—migraine	0.000815	0.00255	CcSEcCtD
Lisdexamfetamine—Immune system disorder—Valproic Acid—migraine	0.000814	0.00255	CcSEcCtD
Lisdexamfetamine—Mediastinal disorder—Valproic Acid—migraine	0.000812	0.00254	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Verapamil—migraine	0.000805	0.00252	CcSEcCtD
Lisdexamfetamine—Somnolence—Verapamil—migraine	0.000803	0.00251	CcSEcCtD
Lisdexamfetamine—Hallucination—Timolol—migraine	0.000798	0.0025	CcSEcCtD
Lisdexamfetamine—Dizziness—Amitriptyline—migraine	0.000797	0.0025	CcSEcCtD
Lisdexamfetamine—SLC6A2—brain—migraine	0.000795	0.0101	CbGeAlD
Lisdexamfetamine—Dyspepsia—Verapamil—migraine	0.000795	0.00249	CcSEcCtD
Lisdexamfetamine—ADRA1B—Calcium Regulation in the Cardiac Cell—CACNA1A—migraine	0.00079	0.0115	CbGpPWpGaD
Lisdexamfetamine—Mental disorder—Valproic Acid—migraine	0.000789	0.00247	CcSEcCtD
Lisdexamfetamine—Hepatobiliary disease—Gabapentin—migraine	0.000787	0.00246	CcSEcCtD
Lisdexamfetamine—Malnutrition—Valproic Acid—migraine	0.000784	0.00246	CcSEcCtD
Lisdexamfetamine—Urticaria—Propranolol—migraine	0.00078	0.00244	CcSEcCtD
Lisdexamfetamine—Fatigue—Verapamil—migraine	0.000778	0.00244	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Propranolol—migraine	0.000776	0.00243	CcSEcCtD
Lisdexamfetamine—Visual impairment—Timolol—migraine	0.000773	0.00242	CcSEcCtD
Lisdexamfetamine—Constipation—Verapamil—migraine	0.000772	0.00242	CcSEcCtD
Lisdexamfetamine—Vomiting—Amitriptyline—migraine	0.000766	0.0024	CcSEcCtD
Lisdexamfetamine—Nervousness—Valproic Acid—migraine	0.000762	0.00238	CcSEcCtD
Lisdexamfetamine—Rash—Amitriptyline—migraine	0.00076	0.00238	CcSEcCtD
Lisdexamfetamine—Dermatitis—Amitriptyline—migraine	0.000759	0.00238	CcSEcCtD
Lisdexamfetamine—Headache—Amitriptyline—migraine	0.000755	0.00236	CcSEcCtD
Lisdexamfetamine—Eye disorder—Timolol—migraine	0.000749	0.00235	CcSEcCtD
Lisdexamfetamine—Hepatitis—Gabapentin—migraine	0.000747	0.00234	CcSEcCtD
Lisdexamfetamine—Cardiac disorder—Timolol—migraine	0.000744	0.00233	CcSEcCtD
Lisdexamfetamine—Hallucination—Gabapentin—migraine	0.000743	0.00233	CcSEcCtD
Lisdexamfetamine—Vision blurred—Valproic Acid—migraine	0.000739	0.00231	CcSEcCtD
Lisdexamfetamine—ADRA1B—Amine ligand-binding receptors—HTR2A—migraine	0.000735	0.0107	CbGpPWpGaD
Lisdexamfetamine—Tremor—Valproic Acid—migraine	0.000735	0.0023	CcSEcCtD
Lisdexamfetamine—Amphetamine—SLC6A4—migraine	0.000728	0.0772	CrCbGaD
Lisdexamfetamine—Immune system disorder—Timolol—migraine	0.000724	0.00227	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Propranolol—migraine	0.000723	0.00226	CcSEcCtD
Lisdexamfetamine—Erectile dysfunction—Topiramate—migraine	0.000723	0.00226	CcSEcCtD
Lisdexamfetamine—Mediastinal disorder—Timolol—migraine	0.000723	0.00226	CcSEcCtD
Lisdexamfetamine—Agitation—Valproic Acid—migraine	0.000721	0.00226	CcSEcCtD
Lisdexamfetamine—Visual impairment—Gabapentin—migraine	0.00072	0.00225	CcSEcCtD
Lisdexamfetamine—Urticaria—Verapamil—migraine	0.000717	0.00225	CcSEcCtD
Lisdexamfetamine—SLC6A3—Transmission across Chemical Synapses—CACNA1A—migraine	0.000717	0.0104	CbGpPWpGaD
Lisdexamfetamine—Angioedema—Valproic Acid—migraine	0.000717	0.00224	CcSEcCtD
Lisdexamfetamine—Nausea—Amitriptyline—migraine	0.000716	0.00224	CcSEcCtD
Lisdexamfetamine—Weight increased—Topiramate—migraine	0.000714	0.00224	CcSEcCtD
Lisdexamfetamine—Weight decreased—Topiramate—migraine	0.00071	0.00222	CcSEcCtD
Lisdexamfetamine—Erythema multiforme—Gabapentin—migraine	0.000706	0.00221	CcSEcCtD
Lisdexamfetamine—Asthenia—Propranolol—migraine	0.000704	0.0022	CcSEcCtD
Lisdexamfetamine—Mental disorder—Timolol—migraine	0.000703	0.0022	CcSEcCtD
Lisdexamfetamine—Malnutrition—Timolol—migraine	0.000698	0.00219	CcSEcCtD
Lisdexamfetamine—Eye disorder—Gabapentin—migraine	0.000698	0.00219	CcSEcCtD
Lisdexamfetamine—Depression—Topiramate—migraine	0.000698	0.00219	CcSEcCtD
Lisdexamfetamine—Stevens-Johnson syndrome—Topiramate—migraine	0.000694	0.00217	CcSEcCtD
Lisdexamfetamine—Cardiac disorder—Gabapentin—migraine	0.000693	0.00217	CcSEcCtD
Lisdexamfetamine—Palpitations—Valproic Acid—migraine	0.000693	0.00217	CcSEcCtD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—ATP1A2—migraine	0.000685	0.00996	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—ATP1A3—migraine	0.000685	0.00996	CbGpPWpGaD
Lisdexamfetamine—Nervousness—Timolol—migraine	0.000678	0.00212	CcSEcCtD
Lisdexamfetamine—Hypertension—Valproic Acid—migraine	0.000677	0.00212	CcSEcCtD
Lisdexamfetamine—Methamphetamine—SLC6A4—migraine	0.000675	0.0715	CrCbGaD
Lisdexamfetamine—Immune system disorder—Gabapentin—migraine	0.000675	0.00211	CcSEcCtD
Lisdexamfetamine—Mediastinal disorder—Gabapentin—migraine	0.000673	0.00211	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Propranolol—migraine	0.000671	0.0021	CcSEcCtD
Lisdexamfetamine—Anxiety—Valproic Acid—migraine	0.000665	0.00208	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Verapamil—migraine	0.000665	0.00208	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000663	0.00208	CcSEcCtD
Lisdexamfetamine—Vision blurred—Timolol—migraine	0.000658	0.00206	CcSEcCtD
Lisdexamfetamine—Mental disorder—Gabapentin—migraine	0.000654	0.00205	CcSEcCtD
Lisdexamfetamine—Dry mouth—Valproic Acid—migraine	0.000653	0.00204	CcSEcCtD
Lisdexamfetamine—Malnutrition—Gabapentin—migraine	0.00065	0.00204	CcSEcCtD
Lisdexamfetamine—Dizziness—Propranolol—migraine	0.000649	0.00203	CcSEcCtD
Lisdexamfetamine—Asthenia—Verapamil—migraine	0.000648	0.00203	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Valproic Acid—migraine	0.00064	0.002	CcSEcCtD
Lisdexamfetamine—Angioedema—Timolol—migraine	0.000638	0.002	CcSEcCtD
Lisdexamfetamine—Nervousness—Gabapentin—migraine	0.000631	0.00198	CcSEcCtD
Lisdexamfetamine—Hepatitis—Topiramate—migraine	0.000628	0.00197	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Valproic Acid—migraine	0.000628	0.00197	CcSEcCtD
Lisdexamfetamine—Hallucination—Topiramate—migraine	0.000625	0.00196	CcSEcCtD
Lisdexamfetamine—Tachycardia—Valproic Acid—migraine	0.000625	0.00196	CcSEcCtD
Lisdexamfetamine—Vomiting—Propranolol—migraine	0.000624	0.00195	CcSEcCtD
Lisdexamfetamine—Skin disorder—Valproic Acid—migraine	0.000622	0.00195	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Valproic Acid—migraine	0.000619	0.00194	CcSEcCtD
Lisdexamfetamine—Rash—Propranolol—migraine	0.000619	0.00194	CcSEcCtD
Lisdexamfetamine—Dermatitis—Propranolol—migraine	0.000618	0.00194	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Verapamil—migraine	0.000618	0.00193	CcSEcCtD
Lisdexamfetamine—Palpitations—Timolol—migraine	0.000617	0.00193	CcSEcCtD
Lisdexamfetamine—Vision blurred—Gabapentin—migraine	0.000613	0.00192	CcSEcCtD
Lisdexamfetamine—Anorexia—Valproic Acid—migraine	0.00061	0.00191	CcSEcCtD
Lisdexamfetamine—Tremor—Gabapentin—migraine	0.000609	0.00191	CcSEcCtD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—TRPM8—migraine	0.000609	0.00884	CbGpPWpGaD
Lisdexamfetamine—Visual impairment—Topiramate—migraine	0.000606	0.0019	CcSEcCtD
Lisdexamfetamine—Hypertension—Timolol—migraine	0.000603	0.00189	CcSEcCtD
Lisdexamfetamine—Agitation—Gabapentin—migraine	0.000597	0.00187	CcSEcCtD
Lisdexamfetamine—Dizziness—Verapamil—migraine	0.000597	0.00187	CcSEcCtD
Lisdexamfetamine—Erythema multiforme—Topiramate—migraine	0.000594	0.00186	CcSEcCtD
Lisdexamfetamine—Angioedema—Gabapentin—migraine	0.000594	0.00186	CcSEcCtD
Lisdexamfetamine—Anxiety—Timolol—migraine	0.000592	0.00185	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.00059	0.00185	CcSEcCtD
Lisdexamfetamine—ADRA1B—G alpha (q) signalling events—HTR2B—migraine	0.000587	0.00853	CbGpPWpGaD
Lisdexamfetamine—Eye disorder—Topiramate—migraine	0.000587	0.00184	CcSEcCtD
Lisdexamfetamine—Cardiac disorder—Topiramate—migraine	0.000583	0.00183	CcSEcCtD
Lisdexamfetamine—Nausea—Propranolol—migraine	0.000583	0.00182	CcSEcCtD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—HTR3A—migraine	0.000583	0.00847	CbGpPWpGaD
Lisdexamfetamine—Dry mouth—Timolol—migraine	0.000581	0.00182	CcSEcCtD
Lisdexamfetamine—Insomnia—Valproic Acid—migraine	0.000579	0.00181	CcSEcCtD
Lisdexamfetamine—Palpitations—Gabapentin—migraine	0.000575	0.0018	CcSEcCtD
Lisdexamfetamine—Vomiting—Verapamil—migraine	0.000574	0.0018	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Valproic Acid—migraine	0.000571	0.00179	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Timolol—migraine	0.00057	0.00178	CcSEcCtD
Lisdexamfetamine—Rash—Verapamil—migraine	0.000569	0.00178	CcSEcCtD
Lisdexamfetamine—Somnolence—Valproic Acid—migraine	0.000569	0.00178	CcSEcCtD
Lisdexamfetamine—Dermatitis—Verapamil—migraine	0.000569	0.00178	CcSEcCtD
Lisdexamfetamine—Immune system disorder—Topiramate—migraine	0.000568	0.00178	CcSEcCtD
Lisdexamfetamine—Mediastinal disorder—Topiramate—migraine	0.000566	0.00177	CcSEcCtD
Lisdexamfetamine—Headache—Verapamil—migraine	0.000566	0.00177	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Valproic Acid—migraine	0.000563	0.00176	CcSEcCtD
Lisdexamfetamine—Convulsion—Gabapentin—migraine	0.000563	0.00176	CcSEcCtD
Lisdexamfetamine—SLC6A2—NRF2 pathway—SLC6A4—migraine	0.000562	0.00817	CbGpPWpGaD
Lisdexamfetamine—Hypertension—Gabapentin—migraine	0.000561	0.00176	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Timolol—migraine	0.000559	0.00175	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Valproic Acid—migraine	0.000556	0.00174	CcSEcCtD
Lisdexamfetamine—Skin disorder—Timolol—migraine	0.000553	0.00173	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Valproic Acid—migraine	0.000553	0.00173	CcSEcCtD
Lisdexamfetamine—Fatigue—Valproic Acid—migraine	0.000552	0.00173	CcSEcCtD
Lisdexamfetamine—Anxiety—Gabapentin—migraine	0.000552	0.00173	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Timolol—migraine	0.000551	0.00172	CcSEcCtD
Lisdexamfetamine—Mental disorder—Topiramate—migraine	0.00055	0.00172	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.00055	0.00172	CcSEcCtD
Lisdexamfetamine—SLC6A3—Neuronal System—CACNA1A—migraine	0.000549	0.00798	CbGpPWpGaD
Lisdexamfetamine—Constipation—Valproic Acid—migraine	0.000547	0.00171	CcSEcCtD
Lisdexamfetamine—Malnutrition—Topiramate—migraine	0.000547	0.00171	CcSEcCtD
Lisdexamfetamine—Anorexia—Timolol—migraine	0.000543	0.0017	CcSEcCtD
Lisdexamfetamine—Dry mouth—Gabapentin—migraine	0.000541	0.00169	CcSEcCtD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—TRPM8—migraine	0.000539	0.00783	CbGpPWpGaD
Lisdexamfetamine—Nausea—Verapamil—migraine	0.000536	0.00168	CcSEcCtD
Lisdexamfetamine—Nervousness—Topiramate—migraine	0.000531	0.00166	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Gabapentin—migraine	0.000531	0.00166	CcSEcCtD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2B—migraine	0.000525	0.00763	CbGpPWpGaD
Lisdexamfetamine—Nervous system disorder—Gabapentin—migraine	0.00052	0.00163	CcSEcCtD
Lisdexamfetamine—Tachycardia—Gabapentin—migraine	0.000518	0.00162	CcSEcCtD
Lisdexamfetamine—Vision blurred—Topiramate—migraine	0.000515	0.00161	CcSEcCtD
Lisdexamfetamine—Skin disorder—Gabapentin—migraine	0.000515	0.00161	CcSEcCtD
Lisdexamfetamine—Insomnia—Timolol—migraine	0.000515	0.00161	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Gabapentin—migraine	0.000513	0.00161	CcSEcCtD
Lisdexamfetamine—Tremor—Topiramate—migraine	0.000512	0.0016	CcSEcCtD
Lisdexamfetamine—Urticaria—Valproic Acid—migraine	0.000508	0.00159	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Timolol—migraine	0.000508	0.00159	CcSEcCtD
Lisdexamfetamine—Somnolence—Timolol—migraine	0.000507	0.00159	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Valproic Acid—migraine	0.000506	0.00158	CcSEcCtD
Lisdexamfetamine—Anorexia—Gabapentin—migraine	0.000506	0.00158	CcSEcCtD
Lisdexamfetamine—Agitation—Topiramate—migraine	0.000503	0.00157	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Timolol—migraine	0.000502	0.00157	CcSEcCtD
Lisdexamfetamine—SLC6A2—Monoamine Transport—TNF—migraine	0.0005	0.00726	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—NRF2 pathway—SLC6A4—migraine	0.000498	0.00723	CbGpPWpGaD
Lisdexamfetamine—Decreased appetite—Timolol—migraine	0.000495	0.00155	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Timolol—migraine	0.000492	0.00154	CcSEcCtD
Lisdexamfetamine—Fatigue—Timolol—migraine	0.000491	0.00154	CcSEcCtD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000488	0.00709	CbGpPWpGaD
Lisdexamfetamine—Palpitations—Topiramate—migraine	0.000483	0.00151	CcSEcCtD
Lisdexamfetamine—Insomnia—Gabapentin—migraine	0.00048	0.0015	CcSEcCtD
Lisdexamfetamine—Convulsion—Topiramate—migraine	0.000474	0.00148	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Gabapentin—migraine	0.000473	0.00148	CcSEcCtD
Lisdexamfetamine—Hypertension—Topiramate—migraine	0.000472	0.00148	CcSEcCtD
Lisdexamfetamine—Somnolence—Gabapentin—migraine	0.000472	0.00148	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Valproic Acid—migraine	0.000472	0.00148	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Gabapentin—migraine	0.000467	0.00146	CcSEcCtD
Lisdexamfetamine—Anxiety—Topiramate—migraine	0.000464	0.00145	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000462	0.00145	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Gabapentin—migraine	0.000461	0.00144	CcSEcCtD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—ATP1A2—migraine	0.000461	0.0067	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—ATP1A3—migraine	0.000461	0.0067	CbGpPWpGaD
Lisdexamfetamine—Asthenia—Valproic Acid—migraine	0.000459	0.00144	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Gabapentin—migraine	0.000458	0.00143	CcSEcCtD
Lisdexamfetamine—Fatigue—Gabapentin—migraine	0.000457	0.00143	CcSEcCtD
Lisdexamfetamine—Dry mouth—Topiramate—migraine	0.000455	0.00143	CcSEcCtD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000454	0.0066	CbGpPWpGaD
Lisdexamfetamine—Constipation—Gabapentin—migraine	0.000454	0.00142	CcSEcCtD
Lisdexamfetamine—Urticaria—Timolol—migraine	0.000453	0.00142	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Timolol—migraine	0.00045	0.00141	CcSEcCtD
Lisdexamfetamine—SLC6A3—Monoamine Transport—TNF—migraine	0.000443	0.00643	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—RAMP1—migraine	0.000439	0.00637	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—CALCRL—migraine	0.000439	0.00637	CbGpPWpGaD
Lisdexamfetamine—Diarrhoea—Valproic Acid—migraine	0.000438	0.00137	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Topiramate—migraine	0.000438	0.00137	CcSEcCtD
Lisdexamfetamine—Tachycardia—Topiramate—migraine	0.000436	0.00136	CcSEcCtD
Lisdexamfetamine—Skin disorder—Topiramate—migraine	0.000434	0.00136	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Topiramate—migraine	0.000432	0.00135	CcSEcCtD
Lisdexamfetamine—Anorexia—Topiramate—migraine	0.000426	0.00133	CcSEcCtD
Lisdexamfetamine—SLC6A2—NRF2 pathway—TGFBR2—migraine	0.000424	0.00616	CbGpPWpGaD
Lisdexamfetamine—Dizziness—Valproic Acid—migraine	0.000423	0.00133	CcSEcCtD
Lisdexamfetamine—Urticaria—Gabapentin—migraine	0.000422	0.00132	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Timolol—migraine	0.00042	0.00131	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Gabapentin—migraine	0.000419	0.00131	CcSEcCtD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000418	0.00608	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—LPA receptor mediated events—FOS—migraine	0.000412	0.00598	CbGpPWpGaD
Lisdexamfetamine—Asthenia—Timolol—migraine	0.000409	0.00128	CcSEcCtD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—ATP1A2—migraine	0.000409	0.00593	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—ATP1A3—migraine	0.000409	0.00593	CbGpPWpGaD
Lisdexamfetamine—Vomiting—Valproic Acid—migraine	0.000407	0.00127	CcSEcCtD
Lisdexamfetamine—Insomnia—Topiramate—migraine	0.000404	0.00126	CcSEcCtD
Lisdexamfetamine—Rash—Valproic Acid—migraine	0.000404	0.00126	CcSEcCtD
Lisdexamfetamine—Dermatitis—Valproic Acid—migraine	0.000403	0.00126	CcSEcCtD
Lisdexamfetamine—Headache—Valproic Acid—migraine	0.000401	0.00126	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Topiramate—migraine	0.000398	0.00125	CcSEcCtD
Lisdexamfetamine—Somnolence—Topiramate—migraine	0.000397	0.00124	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Topiramate—migraine	0.000393	0.00123	CcSEcCtD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—HTR3A—migraine	0.000392	0.0057	CbGpPWpGaD
Lisdexamfetamine—Hypersensitivity—Gabapentin—migraine	0.000391	0.00122	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Timolol—migraine	0.00039	0.00122	CcSEcCtD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000389	0.00565	CbGpPWpGaD
Lisdexamfetamine—Decreased appetite—Topiramate—migraine	0.000388	0.00121	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Topiramate—migraine	0.000385	0.00121	CcSEcCtD
Lisdexamfetamine—Fatigue—Topiramate—migraine	0.000385	0.0012	CcSEcCtD
Lisdexamfetamine—Constipation—Topiramate—migraine	0.000382	0.0012	CcSEcCtD
Lisdexamfetamine—Asthenia—Gabapentin—migraine	0.000381	0.00119	CcSEcCtD
Lisdexamfetamine—Nausea—Valproic Acid—migraine	0.00038	0.00119	CcSEcCtD
Lisdexamfetamine—Dizziness—Timolol—migraine	0.000377	0.00118	CcSEcCtD
Lisdexamfetamine—SLC6A3—NRF2 pathway—TGFBR2—migraine	0.000376	0.00546	CbGpPWpGaD
Lisdexamfetamine—Diarrhoea—Gabapentin—migraine	0.000363	0.00114	CcSEcCtD
Lisdexamfetamine—ADRA1B—G alpha (q) signalling events—NPS—migraine	0.000363	0.00527	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—G alpha (q) signalling events—TAC1—migraine	0.000363	0.00527	CbGpPWpGaD
Lisdexamfetamine—Vomiting—Timolol—migraine	0.000362	0.00113	CcSEcCtD
Lisdexamfetamine—Rash—Timolol—migraine	0.000359	0.00112	CcSEcCtD
Lisdexamfetamine—Dermatitis—Timolol—migraine	0.000359	0.00112	CcSEcCtD
Lisdexamfetamine—Headache—Timolol—migraine	0.000357	0.00112	CcSEcCtD
Lisdexamfetamine—ADRA1B—G alpha (q) signalling events—HTR2C—migraine	0.000356	0.00517	CbGpPWpGaD
Lisdexamfetamine—Urticaria—Topiramate—migraine	0.000355	0.00111	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Topiramate—migraine	0.000353	0.0011	CcSEcCtD
Lisdexamfetamine—Dizziness—Gabapentin—migraine	0.000351	0.0011	CcSEcCtD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—HTR3A—migraine	0.000347	0.00505	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—G alpha (q) signalling events—EDNRA—migraine	0.000346	0.00503	CbGpPWpGaD
Lisdexamfetamine—Nausea—Timolol—migraine	0.000338	0.00106	CcSEcCtD
Lisdexamfetamine—Vomiting—Gabapentin—migraine	0.000337	0.00106	CcSEcCtD
Lisdexamfetamine—Rash—Gabapentin—migraine	0.000335	0.00105	CcSEcCtD
Lisdexamfetamine—Dermatitis—Gabapentin—migraine	0.000334	0.00105	CcSEcCtD
Lisdexamfetamine—Headache—Gabapentin—migraine	0.000332	0.00104	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Topiramate—migraine	0.000329	0.00103	CcSEcCtD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.000325	0.00471	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.000325	0.00471	CbGpPWpGaD
Lisdexamfetamine—Asthenia—Topiramate—migraine	0.00032	0.001	CcSEcCtD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—HTR1D—migraine	0.000319	0.00463	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.000318	0.00462	CbGpPWpGaD
Lisdexamfetamine—Nausea—Gabapentin—migraine	0.000315	0.000987	CcSEcCtD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.00031	0.0045	CbGpPWpGaD
Lisdexamfetamine—Diarrhoea—Topiramate—migraine	0.000305	0.000956	CcSEcCtD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—HTR2B—migraine	0.000296	0.0043	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000296	0.0043	CbGpPWpGaD
Lisdexamfetamine—Dizziness—Topiramate—migraine	0.000295	0.000924	CcSEcCtD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000285	0.00414	CbGpPWpGaD
Lisdexamfetamine—Vomiting—Topiramate—migraine	0.000284	0.000889	CcSEcCtD
Lisdexamfetamine—Rash—Topiramate—migraine	0.000281	0.000881	CcSEcCtD
Lisdexamfetamine—Dermatitis—Topiramate—migraine	0.000281	0.00088	CcSEcCtD
Lisdexamfetamine—Headache—Topiramate—migraine	0.00028	0.000876	CcSEcCtD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000275	0.004	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000268	0.00389	CbGpPWpGaD
Lisdexamfetamine—Nausea—Topiramate—migraine	0.000265	0.00083	CcSEcCtD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000254	0.00368	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CALCRL—migraine	0.000248	0.0036	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—RAMP1—migraine	0.000248	0.0036	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000244	0.00354	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000241	0.0035	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.00024	0.00349	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.00024	0.00349	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000236	0.00342	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000229	0.00333	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CALCRL—migraine	0.000225	0.00327	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—RAMP1—migraine	0.000225	0.00327	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—G alpha (q) signalling events—HTR2A—migraine	0.000218	0.00317	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000206	0.003	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.000195	0.00284	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—HTR1B—migraine	0.000193	0.0028	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—HTR1A—migraine	0.000186	0.0027	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—TAC1—migraine	0.000183	0.00266	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—NPS—migraine	0.000183	0.00266	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—HTR1D—migraine	0.00018	0.00262	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—HTR2C—migraine	0.000179	0.00261	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—EDNRA—migraine	0.000175	0.00254	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000169	0.00245	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—CALCA—migraine	0.000168	0.00244	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—HTR2B—migraine	0.000167	0.00243	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—HTR1D—migraine	0.000164	0.00238	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—HTR7—migraine	0.000157	0.00228	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—HTR2B—migraine	0.000152	0.00221	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000145	0.0021	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—RAMP1—migraine	0.000133	0.00193	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CALCRL—migraine	0.000133	0.00193	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—HTR2A—migraine	0.00011	0.0016	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—HTR1B—migraine	0.000109	0.00158	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—HTR1A—migraine	0.000105	0.00153	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—TAC1—migraine	0.000103	0.0015	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—NPS—migraine	0.000103	0.0015	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—HTR2C—migraine	0.000101	0.00147	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—HTR1B—migraine	9.91e-05	0.00144	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—EDNRA—migraine	9.87e-05	0.00143	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—HTR1D—migraine	9.66e-05	0.0014	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—HTR1A—migraine	9.54e-05	0.00139	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CALCA—migraine	9.5e-05	0.00138	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—NPS—migraine	9.39e-05	0.00136	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—TAC1—migraine	9.39e-05	0.00136	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—HTR2C—migraine	9.21e-05	0.00134	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—HTR2B—migraine	8.98e-05	0.0013	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—EDNRA—migraine	8.96e-05	0.0013	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—HTR7—migraine	8.88e-05	0.00129	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CALCA—migraine	8.63e-05	0.00125	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—HTR7—migraine	8.07e-05	0.00117	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—LRP1—migraine	7.91e-05	0.00115	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—HTR2A—migraine	6.22e-05	0.000904	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—NOTCH4—migraine	6.07e-05	0.000881	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—HTR1B—migraine	5.85e-05	0.00085	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—HTR2A—migraine	5.65e-05	0.000821	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—HTR1A—migraine	5.63e-05	0.000818	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PGR—migraine	5.55e-05	0.000806	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—NPS—migraine	5.55e-05	0.000806	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—TAC1—migraine	5.55e-05	0.000806	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—HTR2C—migraine	5.44e-05	0.00079	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—EDNRA—migraine	5.29e-05	0.000769	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—NOTCH3—migraine	5.16e-05	0.000749	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CALCA—migraine	5.1e-05	0.00074	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—HTR7—migraine	4.77e-05	0.000692	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—TGFBR2—migraine	4.1e-05	0.000596	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—HTR2A—migraine	3.34e-05	0.000485	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ESR1—migraine	2.96e-05	0.00043	CbGpPWpGaD
